Clinical Trial

MEASUREMENT OF CIRCULATING MUTATION BURDEN

Study acronym: cRISK
Recruiting
View on ClinicalTrials.gov →
Summary
Cancer-free women with a hereditary predisposition to breast and/or ovarian cancer
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-01-20; most recent amendment 2025-07-07.
Status change: Not Yet Recruiting → Recruiting 2025-07-07
Trial Details
NCT Number NCT06792721
Lead Sponsor Centre Francois Baclesse
Conditions Breast Carcinoma, Genetic Predisposition to Cancer, BRCA Mutation, cfMB, Mutation Burden
Enrollment 30 participants
Start Date 2025-07-04
Primary Completion 2027-07-15 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-08